产品详情
简单介绍：
GSK-J4,H3K27HistoneDemethylasesUTXandJMJD3Inhibitor
详情介绍：
Product Information
| Molecular Weight: | 417.50 |
| Formula: | C24H27N5O2 |
| Purity: | ≥98% |
| CAS#: | 1373423-53-0 |
| Solubility: | DMSO up to 100 mM |
| Chemical Name: | ethyl 3-((6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoate |
| Storage: | Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year. |
Biological Activity:
GSK-J4 is an ethyl ester derivative of GSK-J1, which is the first selective and potent inhibitor of the H3K27 histone demethylases UTX and JMJD3. The highly polar carboxylate group of GSK-J1 restricts its cellular permeability, therefore GSK-J4 was developed as a pro-drug, masking the polarity of the acid group of the GSK-J1, for cellular assays. GSK-J4 could significant reduce LPS-induced pro-inflammatory cytokine production in primary human macrophages (IC50 ~9 μM for the inhibition of TNFα release). Together with GSK-J1, GSK-J4 could be a unique small molecule to allow selective pharmacological intervention across the JMJ family.
How to Use:
- In vitro: GSK-J4 was used at 30 µM final concentration in cellular assays.
- In vivo: n/a
Reference:
- 1. Kruidenier L, et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response (2012) Nature. 488(7411):404-8.
- 2. SGC website: http://www.thesgc.org/scientists/chemical_probes/GSKJ1
Products are for research use only. Not for human use.
相关文章
